Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

EU rolling review of Russia’s Sputnik V COVID-19 vaccine gets underway

The European Medicines Agency (EMA) has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.

CureVac and Novartis in COVID-19 vaccine manufacturing deal

CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s mRNA based COVID-19 vaccine candidate, CVnCoV.

Allogeneic cell therapy player Century raises $160m in funds to advance pre-clinical pipeline

Century Therapeutics has announced the closing of a US$160m Series C financing round.

Merck to help manufacture J&J COVID-19 vaccine

Merck’s US facilities will help manufacture Johnson & Johnson’s COVID-19 vaccine: which a $268.8m injection from the US government helping it adapt existing facilities for COVID-19 vaccines and medicines.

Pharmaron takes UK biologics plant off AbbVie's hands

China's Pharmaron has entered into a definitive agreement to acquire the Allergan Biologics Limited (ABL) site in Liverpool, UK, for US$118.7m in cash from AbbVie.

Inside the Pfizer/BioNTech COVID-19 vaccine trial: ‘We knew the world was watching and waiting for results’

The 2020 Pfizer/BioNTech COVID-19 vaccine trial recruited more than 44,000 participants and reached submission for emergency authorization in 248 days: showing unprecedented speed and agility in the context of a global pandemic. So what have been the...